Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
Updated: Jul 16, 2020
60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of
ARAKODA (tafenoquine) for COVID-19
Find full press release in attachment below
Tafenoquine Press Release July 2020
.pdf
Download PDF • 202KB
Please find the link and attached document of the published article and findings below
https://www.biorxiv.org/content/10.1101/2020.07.12.199059v1
Dow et al 2020 TQ COVID 19 20200708
.pdf
Download PDF • 324KB